Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Swine Erysipelas Vaccine Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Swine Erysipelas Vaccine Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 102 Pages

Report ld: 1347639

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months.

Swine Erysipelas Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Erysipelas Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Pharmacy and Online Sale are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Swine Erysipelas Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Swine Erysipelas Vaccine key manufacturers include Zoetis, Merck, Boehringer Ingelheim, Qilu Animal Health, CAHIC, Chengdu Tianbang Biology, Jiujiang Bomeilai Biological, Jilin Zhengye Biological and Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., etc. Zoetis, Merck, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.

Swine Erysipelas Vaccine can be divided into Live and Inactivated, etc. Live is the mainstream product in the market, accounting for % sales share globally in 2022.

Swine Erysipelas Vaccine is widely used in various fields, such as Pharmacy, Online Sale and Others,, etc. Pharmacy provides greatest supports to the Swine Erysipelas Vaccine industry development. In 2022, global % sales of Swine Erysipelas Vaccine went into Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Swine Erysipelas Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Zoetis
Merck
Boehringer Ingelheim
Qilu Animal Health
CAHIC
Chengdu Tianbang Biology
Jiujiang Bomeilai Biological
Jilin Zhengye Biological
Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
Hunan Zhong'an Biological Pharmaceutical Co., Ltd.

Segment by Type
Live
Inactivated

Segment by Application
Pharmacy
Online Sale
Others

Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Swine Erysipelas Vaccine market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Erysipelas Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Erysipelas Vaccine industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Swine Erysipelas Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Erysipelas Vaccine introduction, etc. Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Swine Erysipelas Vaccine market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Swine Erysipelas Vaccine Market Overview
    1.1 Swine Erysipelas Vaccine Product Overview
    1.2 Swine Erysipelas Vaccine Market Segment by Type
        1.2.1 Live
        1.2.2 Inactivated
    1.3 Global Swine Erysipelas Vaccine Market Size by Type
        1.3.1 Global Swine Erysipelas Vaccine Market Size Overview by Type (2018-2029)
        1.3.2 Global Swine Erysipelas Vaccine Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Swine Erysipelas Vaccine Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)

 2 Global Swine Erysipelas Vaccine Market Competition by Company
    2.1 Global Top Players by Swine Erysipelas Vaccine Sales (2018-2023)
    2.2 Global Top Players by Swine Erysipelas Vaccine Revenue (2018-2023)
    2.3 Global Top Players by Swine Erysipelas Vaccine Price (2018-2023)
    2.4 Global Top Manufacturers Swine Erysipelas Vaccine Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Swine Erysipelas Vaccine Market Competitive Situation and Trends
        2.5.1 Swine Erysipelas Vaccine Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Swine Erysipelas Vaccine Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Erysipelas Vaccine as of 2022)
    2.7 Date of Key Manufacturers Enter into Swine Erysipelas Vaccine Market
    2.8 Key Manufacturers Swine Erysipelas Vaccine Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Swine Erysipelas Vaccine Status and Outlook by Region
    3.1 Global Swine Erysipelas Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Swine Erysipelas Vaccine Historic Market Size by Region
        3.2.1 Global Swine Erysipelas Vaccine Sales in Volume by Region (2018-2023)
        3.2.2 Global Swine Erysipelas Vaccine Sales in Value by Region (2018-2023)
        3.2.3 Global Swine Erysipelas Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Swine Erysipelas Vaccine Forecasted Market Size by Region
        3.3.1 Global Swine Erysipelas Vaccine Sales in Volume by Region (2024-2029)
        3.3.2 Global Swine Erysipelas Vaccine Sales in Value by Region (2024-2029)
        3.3.3 Global Swine Erysipelas Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Swine Erysipelas Vaccine by Application
    4.1 Swine Erysipelas Vaccine Market Segment by Application
        4.1.1 Pharmacy
        4.1.2 Online Sale
        4.1.3 Others
    4.2 Global Swine Erysipelas Vaccine Market Size by Application
        4.2.1 Global Swine Erysipelas Vaccine Market Size Overview by Application (2018-2029)
        4.2.2 Global Swine Erysipelas Vaccine Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Swine Erysipelas Vaccine Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)

 5 North America Swine Erysipelas Vaccine by Country
    5.1 North America Swine Erysipelas Vaccine Historic Market Size by Country
        5.1.1 North America Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
        5.1.3 North America Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
    5.2 North America Swine Erysipelas Vaccine Forecasted Market Size by Country
        5.2.1 North America Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
        5.2.2 North America Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)

 6 Europe Swine Erysipelas Vaccine by Country
    6.1 Europe Swine Erysipelas Vaccine Historic Market Size by Country
        6.1.1 Europe Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
        6.1.3 Europe Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
    6.2 Europe Swine Erysipelas Vaccine Forecasted Market Size by Country
        6.2.1 Europe Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
        6.2.2 Europe Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)

 7 Asia-Pacific Swine Erysipelas Vaccine by Region
    7.1 Asia-Pacific Swine Erysipelas Vaccine Historic Market Size by Region
        7.1.1 Asia-Pacific Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Swine Erysipelas Vaccine Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Swine Erysipelas Vaccine Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Swine Erysipelas Vaccine Forecasted Market Size by Region
        7.2.1 Asia-Pacific Swine Erysipelas Vaccine Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Swine Erysipelas Vaccine Sales in Value by Region (2024-2029)

 8 Latin America Swine Erysipelas Vaccine by Country
    8.1 Latin America Swine Erysipelas Vaccine Historic Market Size by Country
        8.1.1 Latin America Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
    8.2 Latin America Swine Erysipelas Vaccine Forecasted Market Size by Country
        8.2.1 Latin America Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)

 9 Middle East and Africa Swine Erysipelas Vaccine by Country
    9.1 Middle East and Africa Swine Erysipelas Vaccine Historic Market Size by Country
        9.1.1 Middle East and Africa Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Swine Erysipelas Vaccine Forecasted Market Size by Country
        9.2.1 Middle East and Africa Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Zoetis
        10.1.1 Zoetis Company Information
        10.1.2 Zoetis Introduction and Business Overview
        10.1.3 Zoetis Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Zoetis Swine Erysipelas Vaccine Products Offered
        10.1.5 Zoetis Recent Development
    10.2 Merck
        10.2.1 Merck Company Information
        10.2.2 Merck Introduction and Business Overview
        10.2.3 Merck Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Merck Swine Erysipelas Vaccine Products Offered
        10.2.5 Merck Recent Development
    10.3 Boehringer Ingelheim
        10.3.1 Boehringer Ingelheim Company Information
        10.3.2 Boehringer Ingelheim Introduction and Business Overview
        10.3.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Boehringer Ingelheim Swine Erysipelas Vaccine Products Offered
        10.3.5 Boehringer Ingelheim Recent Development
    10.4 Qilu Animal Health
        10.4.1 Qilu Animal Health Company Information
        10.4.2 Qilu Animal Health Introduction and Business Overview
        10.4.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Qilu Animal Health Swine Erysipelas Vaccine Products Offered
        10.4.5 Qilu Animal Health Recent Development
    10.5 CAHIC
        10.5.1 CAHIC Company Information
        10.5.2 CAHIC Introduction and Business Overview
        10.5.3 CAHIC Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 CAHIC Swine Erysipelas Vaccine Products Offered
        10.5.5 CAHIC Recent Development
    10.6 Chengdu Tianbang Biology
        10.6.1 Chengdu Tianbang Biology Company Information
        10.6.2 Chengdu Tianbang Biology Introduction and Business Overview
        10.6.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Chengdu Tianbang Biology Swine Erysipelas Vaccine Products Offered
        10.6.5 Chengdu Tianbang Biology Recent Development
    10.7 Jiujiang Bomeilai Biological
        10.7.1 Jiujiang Bomeilai Biological Company Information
        10.7.2 Jiujiang Bomeilai Biological Introduction and Business Overview
        10.7.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Products Offered
        10.7.5 Jiujiang Bomeilai Biological Recent Development
    10.8 Jilin Zhengye Biological
        10.8.1 Jilin Zhengye Biological Company Information
        10.8.2 Jilin Zhengye Biological Introduction and Business Overview
        10.8.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Jilin Zhengye Biological Swine Erysipelas Vaccine Products Offered
        10.8.5 Jilin Zhengye Biological Recent Development
    10.9 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
        10.9.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information
        10.9.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Introduction and Business Overview
        10.9.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.9.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Products Offered
        10.9.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Development
    10.10 Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
        10.10.1 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information
        10.10.2 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.10.3 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.10.4 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Products Offered
        10.10.5 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Swine Erysipelas Vaccine Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Swine Erysipelas Vaccine Industrial Chain Analysis
    11.4 Swine Erysipelas Vaccine Market Dynamics
        11.4.1 Swine Erysipelas Vaccine Industry Trends
        11.4.2 Swine Erysipelas Vaccine Market Drivers
        11.4.3 Swine Erysipelas Vaccine Market Challenges
        11.4.4 Swine Erysipelas Vaccine Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Swine Erysipelas Vaccine Distributors
    12.3 Swine Erysipelas Vaccine Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Live
    Table 2. Major Company of Inactivated
    Table 3. Global Swine Erysipelas Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Swine Erysipelas Vaccine Sales by Type (2018-2023) & (K Units)
    Table 5. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Swine Erysipelas Vaccine Market Share in Value by Type (2018-2023)
    Table 8. Global Swine Erysipelas Vaccine Price by Type (2018-2023) & (US$/Unit)
    Table 9. Global Swine Erysipelas Vaccine Sales by Type (2024-2029) & (K Units)
    Table 10. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Swine Erysipelas Vaccine Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Swine Erysipelas Vaccine Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Swine Erysipelas Vaccine Price by Type (2024-2029) & (US$/Unit)
    Table 14. North America Swine Erysipelas Vaccine Sales by Type (2018-2023) & (K Units)
    Table 15. North America Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023)
    Table 17. Europe Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023)
    Table 19. Asia-Pacific Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023)
    Table 21. Latin America Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023)
    Table 23. Middle East and Africa Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Swine Erysipelas Vaccine Sales by Company (2018-2023) & (K Units)
    Table 25. Global Swine Erysipelas Vaccine Sales Share by Company (2018-2023)
    Table 26. Global Swine Erysipelas Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Swine Erysipelas Vaccine Revenue Share by Company (2018-2023)
    Table 28. Global Market Swine Erysipelas Vaccine Price by Company (2018-2023) & (US$/Unit)
    Table 29. Global Swine Erysipelas Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Swine Erysipelas Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Erysipelas Vaccine as of 2022)
    Table 32. Date of Key Manufacturers Enter into Swine Erysipelas Vaccine Market
    Table 33. Key Manufacturers Swine Erysipelas Vaccine Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Swine Erysipelas Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Swine Erysipelas Vaccine Sales by Region (2018-2023) & (K Units)
    Table 37. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Swine Erysipelas Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Swine Erysipelas Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 41. Global Swine Erysipelas Vaccine Sales by Region (2024-2029) & (K Units)
    Table 42. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Swine Erysipelas Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Swine Erysipelas Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
    Table 46. Global Swine Erysipelas Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Swine Erysipelas Vaccine Sales by Application (2018-2023) & (K Units)
    Table 48. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Swine Erysipelas Vaccine Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Swine Erysipelas Vaccine Price by Application (2018-2023) & (US$/Unit)
    Table 52. Global Swine Erysipelas Vaccine Sales by Application (2024-2029) & (K Units)
    Table 53. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Swine Erysipelas Vaccine Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Swine Erysipelas Vaccine Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Swine Erysipelas Vaccine Price by Application (2024-2029) & (US$/Unit)
    Table 57. North America Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) 
    Table 58. North America Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) 
    Table 60. Europe Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) 
    Table 62. Asia-Pacific Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) 
    Table 64. Latin America Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) 
    Table 66. Middle East and Africa Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units)
    Table 68. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units)
    Table 72. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units)
    Table 76. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units)
    Table 80. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2018-2023) & (K Units)
    Table 84. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2024-2029) & (K Units)
    Table 88. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units)
    Table 92. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units)
    Table 96. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units)
    Table 100. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units)
    Table 104. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 107. Zoetis Company Information
    Table 108. Zoetis Introduction and Business Overview
    Table 109. Zoetis Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 110. Zoetis Swine Erysipelas Vaccine Product
    Table 111. Zoetis Recent Development
    Table 112. Merck Company Information
    Table 113. Merck Introduction and Business Overview
    Table 114. Merck Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 115. Merck Swine Erysipelas Vaccine Product
    Table 116. Merck Recent Development
    Table 117. Boehringer Ingelheim Company Information
    Table 118. Boehringer Ingelheim Introduction and Business Overview
    Table 119. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 120. Boehringer Ingelheim Swine Erysipelas Vaccine Product
    Table 121. Boehringer Ingelheim Recent Development
    Table 122. Qilu Animal Health Company Information
    Table 123. Qilu Animal Health Introduction and Business Overview
    Table 124. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 125. Qilu Animal Health Swine Erysipelas Vaccine Product
    Table 126. Qilu Animal Health Recent Development
    Table 127. CAHIC Company Information
    Table 128. CAHIC Introduction and Business Overview
    Table 129. CAHIC Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 130. CAHIC Swine Erysipelas Vaccine Product
    Table 131. CAHIC Recent Development
    Table 132. Chengdu Tianbang Biology Company Information
    Table 133. Chengdu Tianbang Biology Introduction and Business Overview
    Table 134. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 135. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product
    Table 136. Chengdu Tianbang Biology Recent Development
    Table 137. Jiujiang Bomeilai Biological Company Information
    Table 138. Jiujiang Bomeilai Biological Introduction and Business Overview
    Table 139. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 140. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product
    Table 141. Jiujiang Bomeilai Biological Recent Development
    Table 142. Jilin Zhengye Biological Company Information
    Table 143. Jilin Zhengye Biological Introduction and Business Overview
    Table 144. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 145. Jilin Zhengye Biological Swine Erysipelas Vaccine Product
    Table 146. Jilin Zhengye Biological Recent Development
    Table 147. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information
    Table 148. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Introduction and Business Overview
    Table 149. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 150. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product
    Table 151. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Development
    Table 152. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information
    Table 153. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 154. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 155. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product
    Table 156. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Swine Erysipelas Vaccine Market Trends
    Table 160. Swine Erysipelas Vaccine Market Drivers
    Table 161. Swine Erysipelas Vaccine Market Challenges
    Table 162. Swine Erysipelas Vaccine Market Restraints
    Table 163. Swine Erysipelas Vaccine Distributors List
    Table 164. Swine Erysipelas Vaccine Downstream Customers
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Swine Erysipelas Vaccine Product Picture
    Figure 2. Global Swine Erysipelas Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Swine Erysipelas Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Swine Erysipelas Vaccine Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Live
    Figure 6. Global Live Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Inactivated
    Figure 8. Global Inactivated Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Global Swine Erysipelas Vaccine Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Swine Erysipelas Vaccine Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022
    Figure 12. North America Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022
    Figure 13. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Erysipelas Vaccine Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Erysipelas Vaccine Revenue in 2022
    Figure 23. Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Pharmacy
    Figure 25. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units)
    Figure 26. Product Picture of Online Sale
    Figure 27. Global Online Sale Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Others
    Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Global Swine Erysipelas Vaccine Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Swine Erysipelas Vaccine Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022
    Figure 33. North America Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022
    Figure 34. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Swine Erysipelas Vaccine Manufacturing Cost Structure
    Figure 43. Swine Erysipelas Vaccine Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed

Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months.

Swine Erysipelas Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Erysipelas Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Pharmacy and Online Sale are the major drivers for the industry.

Swine Erysipelas Vaccine can be divided into Live and Inactivated, etc. Live is the mainstream product in the market, accounting for % sales share globally in 2022.

Segment by Type
Live
Inactivated

Segment by Application
Pharmacy
Online Sale
Others

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 102 Pages

Report ld: 1347639

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License